From: Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
 | FGFR3 mutation | |||
---|---|---|---|---|
na | neg | pos | P-valueb | |
Immune cell markers: | ||||
 CD3 | ||||
  ≤ 582.3/mm2 | 26 | 22 | 4 | 0.387 |
  > 582.3/mm2 | 36 | 33 | 3 | |
 CD4 | ||||
  ≤ 141.5/mm2 | 29 | 26 | 3 | 0.964 |
  > 141.5/mm2 | 28 | 25 | 3 | |
 CD8 | ||||
  ≤ 291.6/mm2 | 25 | 20 | 5 | 0.039 |
  > 291.6/mm2 | 32 | 31 | 1 | |
 CD68 | ||||
  ≤ 493.0/mm2 | 28 | 27 | 1 | 0.121 |
  > 493.0/mm2 | 32 | 27 | 5 | |
 CD79A | ||||
  ≤ 85.9/mm2 | 30 | 24 | 6 | 0.036 |
  > 85.9/mm2 | 32 | 31 | 1 | |
  CD163 | ||||
  ≤ 462.1/mm2 | 32 | 27 | 5 | 0.307 |
  > 462.1mm2 | 28 | 26 | 2 | |
 Perforin | ||||
  ≤ 9.0/mm2 | 17 | 13 | 4 | 0.022 |
  > 9.0/mm2 | 33 | 32 | 1 |